News Oct 31, 2017 Ghana: Treat unexpected business proposals with caution Business fraud from Ghana and other African countries is currently on the rise. This affects foreign companies, particularly Swiss SMEs with litt...
Webinaire Webinaire: Le mécanisme d’ajustement carbone aux frontières (MACF) expliqué aux entreprises suisses Jun 18, 2024 10:00–11:00
Expertise Dec 12, 2022 EEN: a support network for SMEs seeking partnerships throughout Europe and beyond With negotiations on the future of Swiss-EU relations at a standstill, Swiss SMEs need – now more than ever – to find partnerships to help grow t...
Fact Sheet Aug 30, 2022 EU Directives RoHS and WEEE: This is what Swiss firms need to know The EU directives RoHS II (2011/65/EU) and WEEE (2012/19/EU) of the European Commission restrict the usage of hazardous substances in electr...
Swiss Can AG Machines and complete machine lines to fill and seam cans and jars with powder and dry products
Success stories May 12, 2022 SERV supports educational initiative in Ghana SERV is insuring a buyer credit of EUR 152.6 million to finance the construction of nine vocational training centres in Ghana. In so doing, it is...
Third Party Event SEC Business Luncheon with Martin Hirzel – co-organized with Swissmem Zürich Switzerland
S-GE Event Achieving Switzerland’s climate goals: opportunities for Swiss companies in Ghana and Senegal Event is fully booked Nov 03, 2022 09:30–12:00 Lausanne Switzerland
Country Consulting Export Consulting South-East-Africa Benefit from the expertise of proven experts Zürich Schweiz
Recordings Oct 01, 2021 Energy & Railway EPC projects in Ghana Match with an EPC company operating in the energy and railway sectors in Ghana.
Actualités Sep 25, 2023 Ghana: traitez les propositions commerciales inattendues avec prudence! Les offres frauduleuses en provenance du Ghana et d'autres pays africains connaissent actuellement une forte recrudescence. Sont particulièrement...
AlveoliX AG Life sciences / Biotech / Organs-on-chip / In vitro / Preclinical / Durg Discovery / Drug Development / Animal alternative / MPS